“Hard to Reach” Is a Sponsor Operations Failure, Not a Population Problem
The Lancet calls out "hard to reach" as a stigmatizing label. For clinical ops, it's a site selection failure...
underrepresented populations
The Lancet calls out "hard to reach" as a stigmatizing label. For clinical ops, it's a site selection failure...